Tricarboxylic acid cycle, Succinyl-CoA:3-ketoacid-coenzyme A transferase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: E9AHQ2
Term | Name | Level | Count |
---|---|---|---|
GO:0006091 | generation of precursor metabolites and energy | 3 | 12 |
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016042 | lipid catabolic process | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044248 | cellular catabolic process | 3 | 12 |
GO:0044281 | small molecule metabolic process | 2 | 12 |
GO:0044282 | small molecule catabolic process | 3 | 12 |
GO:0046950 | cellular ketone body metabolic process | 3 | 12 |
GO:0046952 | ketone body catabolic process | 4 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901568 | fatty acid derivative metabolic process | 4 | 12 |
GO:1901569 | fatty acid derivative catabolic process | 5 | 12 |
GO:1901575 | organic substance catabolic process | 3 | 12 |
GO:1902224 | ketone body metabolic process | 4 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008260 | succinyl-CoA:3-oxo-acid CoA-transferase activity | 5 | 12 |
GO:0008410 | CoA-transferase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016782 | transferase activity, transferring sulphur-containing groups | 3 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 24 | 28 | PF00656 | 0.434 |
CLV_C14_Caspase3-7 | 281 | 285 | PF00656 | 0.399 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.203 |
CLV_NRD_NRD_1 | 276 | 278 | PF00675 | 0.197 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.257 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.261 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.203 |
CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 276 | 278 | PF00082 | 0.198 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 414 | 416 | PF00082 | 0.337 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.255 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.255 |
CLV_PCSK_PC1ET2_1 | 252 | 254 | PF00082 | 0.400 |
CLV_PCSK_PC1ET2_1 | 414 | 416 | PF00082 | 0.337 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.280 |
CLV_PCSK_SKI1_1 | 183 | 187 | PF00082 | 0.272 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.219 |
CLV_PCSK_SKI1_1 | 436 | 440 | PF00082 | 0.188 |
CLV_PCSK_SKI1_1 | 441 | 445 | PF00082 | 0.188 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.260 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.252 |
DEG_MDM2_SWIB_1 | 164 | 171 | PF02201 | 0.492 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.439 |
DOC_MAPK_gen_1 | 186 | 195 | PF00069 | 0.399 |
DOC_MAPK_gen_1 | 273 | 282 | PF00069 | 0.421 |
DOC_MAPK_gen_1 | 51 | 59 | PF00069 | 0.448 |
DOC_MAPK_MEF2A_6 | 359 | 367 | PF00069 | 0.388 |
DOC_PP4_FxxP_1 | 202 | 205 | PF00568 | 0.388 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.636 |
DOC_USP7_MATH_1 | 400 | 404 | PF00917 | 0.492 |
DOC_USP7_UBL2_3 | 51 | 55 | PF12436 | 0.470 |
LIG_14-3-3_CanoR_1 | 404 | 410 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 423 | 427 | PF00244 | 0.341 |
LIG_14-3-3_CanoR_1 | 436 | 444 | PF00244 | 0.345 |
LIG_14-3-3_CanoR_1 | 82 | 88 | PF00244 | 0.466 |
LIG_Actin_WH2_2 | 439 | 456 | PF00022 | 0.399 |
LIG_APCC_ABBA_1 | 308 | 313 | PF00400 | 0.477 |
LIG_APCC_ABBA_1 | 57 | 62 | PF00400 | 0.412 |
LIG_EH1_1 | 431 | 439 | PF00400 | 0.492 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.508 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.492 |
LIG_FHA_1 | 433 | 439 | PF00498 | 0.495 |
LIG_FHA_1 | 75 | 81 | PF00498 | 0.464 |
LIG_FHA_2 | 110 | 116 | PF00498 | 0.430 |
LIG_FHA_2 | 459 | 465 | PF00498 | 0.422 |
LIG_Integrin_RGD_1 | 415 | 417 | PF01839 | 0.203 |
LIG_LIR_Apic_2 | 245 | 249 | PF02991 | 0.420 |
LIG_LIR_Gen_1 | 178 | 187 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 284 | 295 | PF02991 | 0.424 |
LIG_LIR_Gen_1 | 353 | 363 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 178 | 182 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 353 | 358 | PF02991 | 0.422 |
LIG_Pex14_2 | 164 | 168 | PF04695 | 0.455 |
LIG_PTB_Apo_2 | 163 | 170 | PF02174 | 0.387 |
LIG_PTB_Phospho_1 | 163 | 169 | PF10480 | 0.387 |
LIG_SH2_CRK | 179 | 183 | PF00017 | 0.492 |
LIG_SH2_CRK | 287 | 291 | PF00017 | 0.403 |
LIG_SH2_CRK | 483 | 487 | PF00017 | 0.408 |
LIG_SH2_GRB2like | 287 | 290 | PF00017 | 0.388 |
LIG_SH2_SRC | 179 | 182 | PF00017 | 0.434 |
LIG_SH2_SRC | 98 | 101 | PF00017 | 0.430 |
LIG_SH2_STAP1 | 128 | 132 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.463 |
LIG_SH2_STAT3 | 133 | 136 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.437 |
LIG_SH3_3 | 228 | 234 | PF00018 | 0.394 |
LIG_SH3_3 | 386 | 392 | PF00018 | 0.412 |
LIG_SUMO_SIM_par_1 | 306 | 313 | PF11976 | 0.497 |
LIG_TRAF2_1 | 17 | 20 | PF00917 | 0.479 |
MOD_CK1_1 | 351 | 357 | PF00069 | 0.388 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.409 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.294 |
MOD_CK2_1 | 255 | 261 | PF00069 | 0.516 |
MOD_Cter_Amidation | 209 | 212 | PF01082 | 0.203 |
MOD_GlcNHglycan | 188 | 192 | PF01048 | 0.199 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.506 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.286 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.193 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.267 |
MOD_GlcNHglycan | 400 | 403 | PF01048 | 0.229 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.279 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.292 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.391 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.434 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.417 |
MOD_GSK3_1 | 422 | 429 | PF00069 | 0.455 |
MOD_GSK3_1 | 432 | 439 | PF00069 | 0.455 |
MOD_N-GLC_1 | 363 | 368 | PF02516 | 0.239 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.544 |
MOD_NEK2_1 | 195 | 200 | PF00069 | 0.388 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.416 |
MOD_NEK2_1 | 363 | 368 | PF00069 | 0.425 |
MOD_NEK2_1 | 371 | 376 | PF00069 | 0.401 |
MOD_NEK2_1 | 398 | 403 | PF00069 | 0.391 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.438 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.409 |
MOD_PIKK_1 | 132 | 138 | PF00454 | 0.492 |
MOD_PKA_1 | 466 | 472 | PF00069 | 0.420 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.479 |
MOD_PKA_2 | 195 | 201 | PF00069 | 0.388 |
MOD_PKA_2 | 422 | 428 | PF00069 | 0.492 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.409 |
MOD_Plk_1 | 363 | 369 | PF00069 | 0.388 |
MOD_Plk_2-3 | 458 | 464 | PF00069 | 0.388 |
MOD_Plk_4 | 363 | 369 | PF00069 | 0.412 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.395 |
MOD_SUMO_rev_2 | 156 | 161 | PF00179 | 0.452 |
TRG_DiLeu_BaLyEn_6 | 70 | 75 | PF01217 | 0.492 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.421 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 211 | 213 | PF00400 | 0.403 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.492 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.492 |
TRG_NLS_Bipartite_1 | 81 | 99 | PF00514 | 0.434 |
TRG_NLS_MonoExtC_3 | 94 | 100 | PF00514 | 0.434 |
TRG_NLS_MonoExtN_4 | 92 | 99 | PF00514 | 0.434 |
TRG_Pf-PMV_PEXEL_1 | 212 | 216 | PF00026 | 0.203 |
TRG_Pf-PMV_PEXEL_1 | 436 | 440 | PF00026 | 0.199 |
TRG_Pf-PMV_PEXEL_1 | 97 | 102 | PF00026 | 0.292 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P584 | Leptomonas seymouri | 41% | 100% |
A0A0N1I0F3 | Leptomonas seymouri | 84% | 100% |
A0A0S4JH09 | Bodo saltans | 62% | 99% |
A0A1X0NIU4 | Trypanosomatidae | 42% | 98% |
A0A1X0P425 | Trypanosomatidae | 64% | 99% |
A0A3Q8IC07 | Leishmania donovani | 45% | 98% |
A0A3Q8IMK1 | Leishmania donovani | 100% | 100% |
A0A3R7LBN6 | Trypanosoma rangeli | 64% | 99% |
A0A3S7X3G0 | Leishmania donovani | 46% | 98% |
A4HLU7 | Leishmania braziliensis | 89% | 100% |
A4I5L8 | Leishmania infantum | 45% | 100% |
A4I5L9 | Leishmania infantum | 46% | 100% |
B2GV06 | Rattus norvegicus | 53% | 94% |
D0A680 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 67% | 99% |
E9B0W3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 47% | 100% |
E9B0W4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 48% | 100% |
E9B473 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
F1CYZ5 | Acetobacterium woodii | 25% | 93% |
P37766 | Escherichia coli (strain K12) | 25% | 92% |
P55809 | Homo sapiens | 53% | 94% |
Q09450 | Caenorhabditis elegans | 53% | 94% |
Q29551 | Sus scrofa | 55% | 94% |
Q4Q3V3 | Leishmania major | 98% | 100% |
Q4Q7A2 | Leishmania major | 47% | 100% |
Q4Q7A3 | Leishmania major | 45% | 99% |
Q54JD9 | Dictyostelium discoideum | 52% | 96% |
Q5XIJ9 | Rattus norvegicus | 52% | 94% |
Q8X5X6 | Escherichia coli O157:H7 | 25% | 92% |
Q9BYC2 | Homo sapiens | 54% | 95% |
Q9D0K2 | Mus musculus | 53% | 94% |
Q9ESL0 | Mus musculus | 53% | 94% |
Q9JJN4 | Mus musculus | 53% | 94% |
Q9W058 | Drosophila melanogaster | 50% | 95% |
V5DQB8 | Trypanosoma cruzi | 64% | 100% |